IP Library Granted Patent US 7,220,400
Granted Patent B2
US 7,220,400 · App. 10/445,696 · Granted May 22, 2007

Compositions for delivering nucleic acids to cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,400
App. No.
10/445,696
Granted
May 22, 2007
Kind
B2
Abstract

Cyclic amidinium containing compounds and their methods of preparation are described. Compositions containing these compounds facilitate delivery of biologically active polymers to cells in vitro and in vivo.

Claims (15)

1. A composition for delivering a polynucleotide to a cell comprising: a cationic poly-cyclic amidinium-containing compound capable of condensing nucleic acid and the polynucteotide.

2. The composition of claim 1 wherein the polynucleotide consists of DNA.

3. The composition of claim 1 wherein the polynucleotide consists of RNA.

4. The composition of claim 1 wherein the polynucleotide consists of an siRNA.

5. The composition of claim 1 wherein the poly cyclic amidinium consists of polyimidazolinium.

6. The composition of claim 1 wherein the poly cyclic amidinium consists of a partially acylated polyethylenimine.

7. The composition of claim 6 wherein the partially acylated polyethylenimine consists of an N-propionyl polyethylenimine derivative.

8. The composition of claim 6 wherein the polyethylenimine consists of linear polyethylenimine.

9. The composition of claim 1 wherein the poly cyclic amidinium consists of partially acylated polyallylamine.

10. The composition of claim 1 wherein the poly cyclic amidinium consists of partially acylatcd polyvinylamine.

11. The composition of claim 1 wherein the cell consists of an in vivo cell.

12. The composition of claim 11 wherein the in vivo cell consists of a lung cell.

13. The composition of claim 11 wherein the in vivo cell consists of a liver cell.

14. The composition of claim 13 wherein the liver cell consists of a hepatocyte.

15. A composition for delivering a polynucleotide to a cell comprising: a cationic poly-cyclic amidinium-containing compound capable of condensing nucleic acid, the polynucleotide and a polyanion in a complex wherein the complex has a negative ζ-potential.

Assignments (1)
CHANGE OF NAME Recorded Apr 6, 2009
From: MIRUS BIO CORPORATION
To: ROCHE MADISON INC.
Reel/Frame 022629/0791 →